Sitemap

• In­sti­tute

  • Of­fi­cial Du­ties
    • Awards
    • Sci­en­tif­ic Ad­vi­so­ry Board
  • Guid­ing Prin­ci­ples
  • Or­gan­i­sa­tion
    • Lead­er­ship Team
    • Di­vi­sion Ad­min­is­tra­tion
    • Di­vi­sion Al­ler­gol­o­gy
    • Di­vi­sion Haema­tol­o­gy / Trans­fu­sion Medicine
    • Di­vi­sion Im­munol­o­gy
    • Di­vi­sion Ma­jor Pol­i­cy Is­sues, Co­or­di­na­tion
    • Di­vi­sion Med­i­cal Biotech­nol­o­gy
    • Di­vi­sion Mi­cro­bi­ol­o­gy
    • Di­vi­sion Safe­ty of Medic­i­nal Prod­ucts and Med­i­cal De­vices
    • Di­vi­sion Vet­eri­nary Medicine
    • Di­vi­sion Vi­rol­o­gy
  • ZEPAI
  • PEI In­ter­na­tion­al
    • Glob­al Health Pro­tec­tion Pro­gramme
    • Our In­volve­ment in the CHMP
  • WHO Col­lab­o­rat­ing Cen­tres
    • Blood Prod­ucts and IVD De­vices
    • Stan­dard­iza­tion and Eval­u­a­tion of Vac­cines
  • His­to­ry of the Paul-Ehrlich-In­sti­tut
  • Por­trait of Paul Ehrlich
  • Bi­ol­o­gy As­so­ci­a­ton

• Medic­i­nal Prod­ucts

  • Vac­cines
    • Sup­ply Short­ages
    • Com­bi­na­tion Vac­cines
    • An­thrax Vac­cines
    • Cholera Vac­cines
    • COVID-19 Vac­cines
    • Dengue Fever Vac­cines
    • Diph­the­ria Vac­cines
    • Ebo­la Vac­cines
    • Haemophilus In­fluen­zae, Type B (HIB) Vac­cines
    • Hep­ati­tis A Vac­cines
    • Hep­ati­tis B Vac­cines
    • HPV Vac­cines
    • In­fluen­za (Flu) Vac­cines
    • Japanese En­cephali­tis Vac­cines
    • Measles Vac­cines
    • Meningo­coc­ci Vac­cines
    • Mumps Vac­cines
    • Per­tus­sis (Whoop­ing Cough) Vac­cines
    • Pneu­mo­coc­cal Vac­cines
    • Po­liomyeli­tis (Po­lio) Vac­cines
    • Ra­bies Vac­cines
    • Ro­tavirus-In­fec­tion Vac­cines
    • Rubel­la (Ger­man Measles) Vac­cines
    • Shin­gles Vac­cines
    • Small­pox Vac­cines
    • Tetanus Vac­cines
    • Tick-Borne En­cephali­tis (TBE) Vac­cines
    • Ty­phoid Fever Vac­cines
    • Vari­cel­la (Chick­en Pox) Vac­cines
    • Yel­low Fever Vac­cines
  • Al­ler­gens
    • Test Al­ler­gens for Epi­cu­ta­neous Tests
    • Test Al­ler­gens for In­tra­cu­ta­neous Tests
    • Test Al­ler­gens for Prick Tests
    • Test Al­ler­gens for Provo­ca­tion Tests
    • Al­ler­gens for Oral Ther­a­py
    • Al­ler­gens for Sub­cu­ta­neous Ther­a­py
    • Al­ler­gens for Sub­lin­gual Ther­a­py
    • Mar­ketable Test Al­ler­gens
    • Mar­ketable Ther­a­peu­tic Al­ler­gens ac­cord­ing to TAV
  • An­ti­bod­ies
    • Im­munoglob­u­lin Prepa­ra­tions
    • Mon­o­clon­al An­ti­bod­ies
    • Sera (Donor An­i­mals)
  • ATMP
    • Gene Ther­a­py Medic­i­nal Prod­ucts
    • So­mat­ic Cell Ther­a­py Medic­i­nal Prod­ucts
    • Tis­sue En­gi­neered Prod­ucts
    • Tu­mor Vac­cines
  • Blood Prod­ucts
    • Al­bu­mins
    • Co­ag­u­la­tion Fac­tors
    • Co­ag­u­la­tion In­hibitors
    • Ery­thro­cyte Con­cen­trate
    • Fib­rin Sealant
    • Plas­ma
    • Platelet Con­cen­trate
    • Oth­er Blood Prod­ucts
  • Stem Cell Prepa­ra­tions
  • Tis­sue Prepa­ra­tions
    • Am­ni­ot­ic Mem­brane
    • Blood Ves­sels
    • Bone Prepa­ra­tions
    • Car­ti­lage Tis­sue
    • Cornea
    • Femoral Head
    • Heart Valves
    • Nerves
    • Scle­ra
    • Skin
    • Soft Tis­sue
  • Oth­ers (Hu­man Use)
  • Im­muno­log­i­cal Vet­eri­nary Medicines
    • Cats
    • Cat­tle
    • Dogs
    • Fer­rets
    • Fish
    • Fox­es and Rac­coon Dogs
    • Goats
    • Hors­es
    • Minks
    • Pigs
    • Poul­try
    • Rab­bits
    • Sheep

• Medicine Safe­ty

  • Phar­ma­covig­i­lance
    • Ad­verse Drug Re­ac­tions Database
  • Haemovig­i­lance
    • Re­port­ing Forms / On­line Re­port­ing
    • Cur­rent Grad­u­at­ed Plan Pro­ce­dures and No­ti­fi­ca­tions
    • Closed Grad­u­at­ed Plan Pro­ce­dures and No­ti­fi­ca­tions
    • Database Stan­dard­ized Blood Donor De­fer­ral
    • Query Blood Do­na­tion Ser­vices Sup­ply Sit­u­a­tion
    • Haemovig­i­lance Re­ports
    • Guide­lines and Rec­om­men­da­tions
    • Pub­li­ca­tions
    • Con­tact
  • Tis­sue Vig­i­lance
    • Re­port­ing Forms
    • Pub­li­ca­tions
    • Con­tact
  • Vig­i­lance of In Vit­ro Di­ag­nos­tics (IVD)
    • Pub­li­ca­tions
    • Con­tact
  • ATMP Vig­i­lance
  • Phar­ma­covig­i­lance (Vet­eri­nary)
    • Pub­li­ca­tions
  • Safe­ty In­for­ma­tion (Hu­man)
  • Ed­u­ca­tion­al Ma­te­ri­al

• Reg­u­la­tion

  • Ad­vice
    • Ad­vice Con­cept
    • Project Ini­tia­tives
    • In­no­va­tion Of­fice
  • Clin­i­cal Tri­als
    • Con­tact Point for those Af­fect­ed
    • Clin­i­cal Tri­als Dur­ing the COVID-19 Pan­dem­ic
    • Time lines for CTA
    • Pro­cess­ing Statis­tics
    • Vol­un­tary Har­mon­i­sa­tion Pro­ce­dure (VHP)
    • In­for­ma­tion on Au­tho­ri­sa­tion Pro­cess­es
    • Ap­pli­ca­tion Ob­ser­va­tions
    • Com­pas­sion­ate Use Pro­grammes
    • Non Com­mer­cial Clin­i­cal Tri­als
    • Reg­is­ter
    • Clin­i­cal Tri­al Au­tho­ri­sa­tions with GMO
    • Per­for­mance Stud­ies with In Vit­ro Com­pan­ion Di­ag­nos­tics (CDx)
    • Trans­mis­sion of Re­sult Re­ports pur­suant to § 42b AMG
    • Elec­tron­ic Sub­mis­sion
    • Votes on Clin­i­cal Tri­als
    • Fees
    • Sta­bil­i­ty Pro­to­col
  • Mar­ket­ing Au­tho­ri­sa­tion (Hu­man)
    • Per­mits
    • Au­tho­ri­sa­tions
    • Post-Au­tho­ri­sa­tion Pro­ce­dures
    • TSE Con­for­mi­ty
    • Al­ter­na­tive Meth­ods to An­i­mal Tests
    • WHO Cer­tifi­cates
    • Prod­uct In­for­ma­tion
    • Ed­u­ca­tion­al Ma­te­ri­al
    • Blood Com­po­nents
    • Par­al­lel Trade
  • Mar­ket­ing Au­tho­ri­sa­tion (Vet­eri­nary)
    • Cen­tralised Pro­ce­dure
    • De­cen­tralised Pro­ce­dure
    • MR Pro­ce­dure
    • Na­tion­al Pro­ce­dure
    • Fol­low-up Pro­ce­dures
    • Field Tri­als
    • ITAM
    • Ap­pli­ca­tion and Sub­mis­sion of Doc­u­ments
  • Ap­provals
    • Au­tho­ri­sa­tion of ATMP
    • Stem Cell Prepa­ra­tions
    • Tis­sue Prepa­ra­tions
  • Batch Test­ing (Hu­man)
    • Ex­per­i­men­tal Batch Test­ing
    • Batch Test­ing of Medicines Trad­ed in Par­al­lel
    • Cer­tifi­cates
  • Batch Test­ing (Vet­eri­nary)
    • Of­fi­cial Batch Pro­to­col Re­view
    • Ex­per­i­men­tal Test­ing
    • Cer­tifi­cates
  • In­spec­tions
    • With the Par­tic­i­pa­tion of PEI-Ex­perts
    • Con­duct­ed by PEI
  • Ref­er­ence Ma­te­ri­al
  • Elec­tron­ic Sub­mis­sion
    • Chan­nels
    • For­mats
    • FAQ
  • Fees
  • Test­ing Lab­o­ra­to­ry IVD
  • Re­port­ing Obli­ga­tions
    • DHR - Ger­man Haemophil­ia Reg­is­ter
    • Preim­plan­ta­tion Ge­net­ic Di­ag­no­sis
    • Re­port § 21 TFG
    • Re­port § 8d TPG
    • Re­port­ing and No­ti­fi­ca­tion Obli­ga­tion for ATMPs
    • No­ti­fi­ca­tions § 29 AMG (Sun­set Clause)
    • Re­port § 28 Tier­Impf­StV (Sun­set Clause)
  • Qual­i­ty Man­age­ment

• Re­search

  • Re­search Groups
    • Molec­u­lar Biotech­nol­o­gy and Gene Ther­a­py
    • Molec­u­lar Al­ler­gol­o­gy
    • Al­ler­gol­o­gy
    • Haema­tol­o­gy and Trans­fu­sion Medicine
    • Im­munol­o­gy
    • Med­i­cal Biotech­nol­o­gy
    • Mi­cro­bi­ol­o­gy
    • Safe­ty of Medic­i­nal Prod­ucts and Med­i­cal De­vices
    • Vet­eri­nary Medicine
    • Vi­rol­o­gy
    • Host-Pathogen In­ter­ac­tions
    • Elec­tron Mi­croscopy of Pathogens
  • Pro­mo­tion of Young Sci­en­tists
  • Re­search and Third-Par­ty Fund­ing
  • Re­search Awards
    • Lan­gen Sci­ence Award
    • Lan­gen Ju­nior Sci­ence Award
  • Pub­li­ca­tions

• News­room

  • News
  • Press Re­leas­es
  • Po­si­tions
  • PEI Bi­en­ni­al Re­ports
  • Manda­to­ry Re­ports
  • So­cial Me­dia
  • Events
    • IPES 2023
  • Pub­li­ca­tions on Medicines
  • Videos, Au­dios and In­fo­graph­ics
  • WHO CC An­nu­al Re­ports
  • Cen­tralised Au­tho­ri­sa­tions
  • Coro­n­avirus and COVID-19
  • Brex­it
  • HIV Self-tests
  • No­ti­fi­ca­tions for Med­i­cal and Phar­ma­ceu­ti­cal Pro­fes­sion­als

• Ser­vice

  • Get­ting to PEI
  • Li­brary
  • Ex­ter­nal Ser­vice Provider
  • FAQ
    • Coro­n­avirus
  • Forms
    • Safe­ty of Medic­i­nal Prod­ucts
    • Ref­er­ence Ma­te­ri­al
    • Reg­u­la­tion
  • Closed Us­er Groups
  • Glos­sary
  • Ca­reer
    • Work­ing at the Paul-Ehrlich-In­sti­tut
    • Ju­nior Sci­en­tists
    • Vo­ca­tion­al Train­ing
    • Fam­i­ly Friend­li­ness
    • In­clu­sion
    • Job Op­por­tu­ni­ties
    • Peo­ple at PEI
  • Newslet­ter
  • Press
    • Lat­est News
    • Press Re­leas­es
    • Press Kit
    • Press Pho­tos
  • Le­gal As­pects
  • Do­na­tions

top